Jennison Associates
SWAV

Jennison Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Jennison Associates’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-65,449
Closed -$21.3M – 618
2024
Q1 		$21.3M Sell
65,449
-35,102
-35% -$8.62M 0.01% 336
2023
Q4 		$19.2M Buy
100,551
+11,651
+13% +$2.2M 0.01% 333
2023
Q3 		$17.7M Buy
+88,900
New +$21M 0.02% 327
2023
Q2 		– Sell
-4,168
Closed -$904K – 635
2023
Q1 		$904K Sell
4,168
-76,924
-95% -$15M ﹤0.01% 505
2022
Q4 		$16.7M Sell
81,092
-1,035
-1% -$262K 0.02% 342
2022
Q3 		$22.8M Sell
82,127
-72,514
-47% -$18.4M 0.02% 307
2022
Q2 		$29.6M Sell
154,641
-278,893
-64% -$49.2M 0.03% 253
2022
Q1 		$89.9M Buy
433,534
+215,142
+99% +$35.5M 0.07% 132
2021
Q4 		$38.9M Sell
218,392
-73,022
-25% -$14.4M 0.02% 265
2021
Q3 		$60M Buy
291,414
+1,826
+0.6% +$359K 0.04% 186
2021
Q2 		$54.9M Sell
289,588
-237,326
-45% -$38.8M 0.04% 212
2021
Q1 		$68.6M Sell
526,914
-50,192
-9% -$6.02M 0.05% 175
2020
Q4 		$59.9M Sell
577,106
-5,828
-1% -$505K 0.04% 178
2020
Q3 		$44.2M Buy
582,934
+1,926
+0.3% +$109K 0.04% 204
2020
Q2 		$27.5M Buy
581,008
+2,950
+0.5% +$122K 0.02% 248
2020
Q1 		$19.2M Sell
578,058
-2,276
-0.4% -$90.4K 0.02% 260
2019
Q4 		$25.5M Buy
580,334
+276,907
+91% +$10.2M 0.03% 278
2019
Q3 		$9.08M Buy
303,427
+105,095
+53% +$4.46M 0.01% 412
2019
Q2 		$11.3M Sell
198,332
-14,134
-7% -$686K 0.01% 421
2019
Q1 		$7.11M Buy
+212,466
New +$7.06M 0.01% 452

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jennison Associates's SWAV Position: Q2 2024 in Review

Jennison Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 65,449 shares — an estimated $21.3M sold.

Jennison Associates first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $89.9M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Jennison Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jennison Associates sold 65,449 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $21.3M.
  • Jennison Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Jennison Associates's Shockwave Medical, Inc. Common Stock position peaked at $89.9M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.